Breaking Down Silos in Drug Development – Why interdisciplinary integration is fundamental for pharma’s future
Posted in Archive
| Tagged ADME / Tox, AI / data analytics / healthtech / informatics, Automation / robotics, Business, Cell culture, Chemical engineering, Clinical trials, Drug development, Drug discovery, Enabling technologies, High Content Screening, Immunology, Lead discovery, Molecular medicine, Regulatory, RNA, System biology, Toxicology
